[
  {
    "ts": null,
    "headline": "Gilead Sciences, US government settle patent case over HIV prevention drugs",
    "summary": "Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court....",
    "url": "https://finnhub.io/api/news?id=d9f648a3660b754217d552404855621f99dbf505d58996ff58d4dc17ad649989",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736955880,
      "headline": "Gilead Sciences, US government settle patent case over HIV prevention drugs",
      "id": 132401336,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court....",
      "url": "https://finnhub.io/api/news?id=d9f648a3660b754217d552404855621f99dbf505d58996ff58d4dc17ad649989"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences : Statement on Successful Resolution with U.S. Department of Justice and the Department of Health and Human Services on Patents",
    "summary": "Foster City, Calif., January 15, 2025 - Gilead Sciences, Inc. today announced it has reached a final settlement agreement with the U.S. Department of Justice and the U.S. Department of Health and...",
    "url": "https://finnhub.io/api/news?id=6c89c70658c1a821f58e78172be99434f5dafa23e810aef8a7189b17b7208ab8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736949664,
      "headline": "Gilead Sciences : Statement on Successful Resolution with U.S. Department of Justice and the Department of Health and Human Services on Patents",
      "id": 132400969,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Foster City, Calif., January 15, 2025 - Gilead Sciences, Inc. today announced it has reached a final settlement agreement with the U.S. Department of Justice and the U.S. Department of Health and...",
      "url": "https://finnhub.io/api/news?id=6c89c70658c1a821f58e78172be99434f5dafa23e810aef8a7189b17b7208ab8"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Value Fund Q4 2024 Commentary",
    "summary": "Strategy outperformed its Russell 1000 Value benchmark during 4Q, as positive contributions from stock selection and sector allocation effects contributed to relative performance.",
    "url": "https://finnhub.io/api/news?id=16104d7a68c2939ee98b902963633ee224985f62212a98b4fd4a0b33be489f73",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736925600,
      "headline": "ClearBridge Value Fund Q4 2024 Commentary",
      "id": 132399220,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Strategy outperformed its Russell 1000 Value benchmark during 4Q, as positive contributions from stock selection and sector allocation effects contributed to relative performance.",
      "url": "https://finnhub.io/api/news?id=16104d7a68c2939ee98b902963633ee224985f62212a98b4fd4a0b33be489f73"
    }
  }
]